Addition of ovarian function suppression to endocrine therapy in premenopausal women with early breast cancer: A meta-analysis

被引：0
|
作者：
Chlebowski, R. [1 ,2 ]
Pan, K.
Col, N. F.
机构：
[1] Los Angeles BioMed Res Inst, Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[2] Univ New England, Portland, ME USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-09-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-06
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Ovarian ablation by radiotherapy; is it still an option for the ovarian function suppression in endocrine responsive premenopausal breast cancer patients?
    Bese, N. S.
    Iribas, A.
    Oksuz, D. C.
    Atkovar, G.
    Ober, A.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 341S - 341S
  • [42] Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer A network meta-analysis
    Jiang, Mengjie
    Chen, Wuzhen
    Hu, Yujie
    Chen, Chao
    Li, Huafeng
    [J]. MEDICINE, 2021, 100 (33)
  • [43] Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis
    Underwood, E. A.
    Rochon, P. A.
    Moineddin, R.
    Lee, P. E.
    Wu, W.
    Pritchard, K. I.
    Tierney, M. C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 299 - 310
  • [44] Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis
    E. A. Underwood
    P. A. Rochon
    R. Moineddin
    P. E. Lee
    W. Wu
    K. I. Pritchard
    M. C. Tierney
    [J]. Breast Cancer Research and Treatment, 2018, 168 : 299 - 310
  • [45] Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer
    Figg, William D., II
    Cook, Katherine
    Clarke, Robert
    [J]. CANCER BIOLOGY & THERAPY, 2014, 15 (12) : 1586 - 1587
  • [46] Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer
    Xue, Cong
    Peng, Roujun
    Cao, Ye
    Wang, Shusen
    Shi, Yanxia
    An, Xin
    Xu, Fei
    Yuan, Zhongyu
    [J]. PLOS ONE, 2016, 11 (02):
  • [47] Cardiovascular and metabolic effects of ovarian suppression as adjuvant therapy for early breast cancer: a systematic review and meta-analysis
    Gue, Ying
    [J]. CARDIOVASCULAR RESEARCH, 2022, 118 (SUPP 2)
  • [48] Ovarian function suppression in premenopausal patients with concurrent endocrine therapy use.
    Grogan, Nicole Margo
    Li, Yajing
    Kidwell, Kelley M.
    Henry, Norah Lynn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] The timing of ovarian function suppression (OFS) with chemotherapy in premenopausal women with endocrine-responsive HER2-negative early breast cancer: a secondary analysis of TEXT and SOFT
    Regan, M. M.
    Walley, B. A.
    Francis, P. A.
    Fleming, G. F.
    Colleoni, M.
    Gelber, R. D.
    Coates, A. S.
    Goldhirsch, A.
    Pagani, O.
    [J]. BREAST, 2017, 32 : S28 - S28
  • [50] Endocrinology and hormone therapy in breast cancer - Endocrine therapy in premenopausal women
    Pritchard, K
    [J]. BREAST CANCER RESEARCH, 2005, 7 (02) : 70 - 76
12345